arrow
J

Johanna Lempainen

University of Turku
H指数:24
被引数:3,625

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of HLA class II haplotypes with antibody concentrations after diphtheria-tetanus acellular pertussis booster vaccination in four age groups of Finnish participants

HLA-II类单倍型与四组芬兰受试者接种白喉-破伤风无细胞百日咳加强疫苗后抗体浓度的关联

Vaccine
IF3.5
2026-05-150
OAAI
Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study: comparison between genetically susceptible children with and without an affected first-degree relative

胰岛自身免疫及进展至1型糖尿病在芬兰DIPP研究中的比较:具有遗传易感性且有无受累一级亲属的儿童对比研究

2025-11-080
OAAI
Corrigendum to “Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1” [Vaccine 68 (2025) 127894]

勘误:关于“疫苗和突破性感染诱导的SARS-CoV-2特异性抗体对奥密克戎亚变种BA.2、XBB.1.5和JN.1的长期中和能力” [Vaccine 68 (2025) 127894]

Vaccine
IF3.5
2025-11-070
OAAI
Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1

疫苗和突破性感染诱导的SARS-CoV-2特异性抗体对奥密克戎亚谱系BA.2、XBB.1.5和JN.1的长期中和能力

Vaccine
IF3.5
2025-10-280
OAAI
Dermal IgA is rare in Celiac Disease and relatives, and lacks Dermatitis Herpetiformis-type co-localization with Transglutaminase 3

在乳糜泻及其亲属中,真皮IgA较为罕见,且与转谷氨酰胺酶3缺乏疱疹样皮炎型的共定位。

2025-10-160
OAAI
Distinct cellular immune responses in children en route to type 1 diabetes with different first-appearing autoantibodies

患有不同首次出现的自身抗体的1型糖尿病患儿的不同细胞免疫反应

2024-05-071
OAAI
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection
2024-02-234
OA